Aurora challenges Curaleaf's hostile bid over regulatory breaches, urges shareholders to reject it.

Aurora Cannabis has filed a formal complaint with the Alberta Securities Commission, accusing Curaleaf of failing to meet key securities law requirements in its hostile takeover bid. Aurora claims Curaleaf's bid lacks necessary pro forma financials, did not remain open for the legally required minimum period, and failed to provide French-language notices, potentially limiting shareholder information and decision-making time. Aurora's board unanimously recommends shareholders reject Curaleaf's offer and not tender their shares, emphasizing the bid undervalues Aurora and disregards shareholder rights. The case now awaits regulatory review to enforce compliance and protect shareholder interests.

Aurora Cannabis has a market cap of $270.67 million and an enterprise value of $215.56 million as of September 24, 2026, 05:41 WIB. On Pluang, the stock is trading at USD 4.22 with a 1-day decline of 1.17%, and the platform shows a 100% sell order activity. The typical hold time for Aurora Cannabis shares on Pluang is 26 days, indicating moderate investor engagement during this regulatory dispute.